Protalix BioTherapeutics, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2013
Total Assets: $113.3M
Liabilities Breakdown FY2013
Total Liabilities: $140.3M
Asset Breakdown
Total Assets: $113.3M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $86.4M | 76.2% |
| Accounts Receivable | $2.1M | 1.8% |
| Inventory | $8.0M | 7.0% |
| Property, Plant & Equipment | $13.7M | 12.1% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $3.2M | 2.8% |
Liabilities Breakdown
Total Liabilities: $140.3M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $5.3M | 3.7% |
| Long-Term Debt | $2.4M | 1.7% |
| Other Liabilities | $132.7M | 94.6% |